Natus Medical (NTUS) develops products and services for the health of babies. This is one area where people are willing to spend as much money as necessary which means NTUS has major upside or could be an acquisition target.Medical device stocks tend to outperform in the long term but are considered to be boring. In certain market conditions, this is a blessing as they tend to have stable revenues and pay above-average dividends. However, even within this group, we can find stocks that are at the beginning of their growth journeys whose stocks can outperform. One area of healthcare that is seeing innovation and also patients are willing to spend massive sums is on the health and wellbeing of newborns. Below, we highlight one of the most intriguing under-the-radar medical device stocks in this space. That stock is Natus Medical (NTUS).
NTUS Background
NTUS has been in business since the late 80s. The company went public in 2001. However, NTUS remained a small-cap stock for decades. Part of what has held the company back is its lack of significant revenue growth in recent years.